Mental Stress, Frontal Lobe Activation and Chest Pain

Historically, we have believed that mental stress might induce chest pain as a response to increased levels of catecholamines and consequently increased product (by 100%), just as it happens with physical stress. 

Stress mental, activación de la corteza frontal y angina de pecho

This innovative study published in Circ Cardiovasc Imaging shows the activation of specific areas in the brain is independently associated with chest pain and other painful processes in the context of mental stress. 

The inferior frontal cortex is an area in the brain involved in stress response. Higher activation of this area stimulated by acute mental stress might accelerate this response and the whole cascade of defense mechanisms. The first was well known, but there was no known correlation between this area in the brain and chest pain in coronary artery disease (CAD) patients. 

The study included 148 patients with stable CAD exposed to mental stress and used a standardized series of tests while doing a high-resolution positron-emission CT scan to see what areas in the brain were activated and when. 


Read also: Watch again Selected Topics in Hemodynamics III.


Every time the inferior frontal cortex increased its activity by 100% vs baseline levels, chest pain rose up to 14 points compared to resting values (Seattle Angina Questionnaire) which resulted significative (p=0.008). 

Activation of other areas in the brain where pain is processed (thalamus, insula and amygdala) only accounted for, in best of cases, 40% of the total effect of the inferior frontal lobe activation on angina severity. 

It also had an effect on chest pain at follow-up.

Conclusion

Inferior frontal love activation induced by mental stress is independently associated to angina symptom severity and frequency. 

Original Title: Association Between Mental Stress- Induced Inferior Frontal Cortex Activation and Angina in Coronary Artery Disease.

Reference: Kasra Moazzami et al. Circ Cardiovasc Imaging. 2020;13:e010710. DOI: 10.1161/CIRCIMAGING.120.010710.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...